World-renowned radiology expert named chair of U-M Department of Radiology

The University of Michigan Board of Regents approved Vikas Gulani, M.D., Ph.D., as the chair of the Department of Radiology

Author | Mary Masson

Vikas Gulani, M.D., Ph.D., has been named chair of the University of Michigan Department of Radiology and the Fred Jenner Hodges Professor of Radiology, effective July 1, 2019. The Board of Regents approved both appointments.

Gulani comes to U-M from the Case Western Reserve University (CWRU) School of Medicine, where he served as the Joseph T. Wearn Professor and a professor of radiology, urology and biomedical engineering. He also was director of MRI and body MRI for University Hospitals Case Medical Center, co-director of the Prostate Cancer Imaging Group and member of the Cancer Imaging Program at the Case Comprehensive Cancer Center.

After earning a Bachelor of Science in chemical engineering from the University of California, Los Angeles, he received a Master of Science, Ph.D. in physiology under Nobel Laureate Paul Lauterbur, Ph.D. Gulani’s M.D. hails from the University of Illinois at Urbana-Champaign (UIUC).

He completed his intern year in internal medicine and residency in diagnostic radiology at UIUC and U-M, respectively, and continued on to complete a postdoctoral fellowship in physics at the University of Würzburg in Germany and fellowship in body MRI at U-M.

Gulani began his academic career at CWRU, where he worked in body imaging, computed tomography, diagnostic radiology, genitourinary procedures, MRI and ultrasound. He is a respected leader in MR research who focuses on technology development and translation in MRI, with primary areas of emphasis that include MR relaxometry, perfusion, diffusion, body MRI, and image acquisition and reconstruction.

He has been named a Distinguished Investigator by the Academy of Radiology Research and elected fellow of the International Society of Magnetic Resonance in Medicine.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Featured News & Stories hospital.jpg
News Release
Michigan Medicine part of research group awarded $15 million to study inflammation's impact on heart, brain health
Research teams from Michigan Medicine, Northwestern University and University of Pittsburgh will lead a $15 million project dedicated to studying inflammation’s role in cardiac and brain diseases. The specific work by Michigan Medicine will focus on the driving forces behind inflammatory processes linked to aging and obesity and how to prevent inflammation that could lead to heart failure, dementia and other diseases.
Florescent image of a human ovarian follicle
Health Lab
Spatial atlas of the human ovary with cell-level resolution will bolster reproductive research
New map of the ovary provides a deeper understanding of how oocytes interact with the surrounding cells during the normal maturation process, and how the function of the follicles may break down in aging or fertility related diseases.
Photo of hand gripping the bannister on a stairway
Health Lab
Addressing fall risks in people with multiple sclerosis
Among people with multiple sclerosis in the United States, more than half experienced at least one fall in a six-month period and approximately one-third of those falls resulted in an injury.
Health Lab
What parents should know about teen drug and alcohol use
An expert from the University of Michigan Addiction Center shares the impacts of teen substance use and what families can do to help youth who may be at risk or showing signs of addiction.
Young man with neck collar in hospital gown poses with his mom in hospital
Health Lab
Long road of rehab: young man recovers after cascade of serious health issues
After a series of life altering health setbacks following a devastating crash, Gabe Villanueva’s is on an extraordinary journey of survival thanks to the highly skilled team at University of Michigan Health.
Illustration of red blood cells and bacteria in the bloodstream
Health Lab
New device can treat injury from sepsis
The FDA approved the use of a therapeutic device invented and developed at the University of Michigan for use in children with acute kidney injury and sepsis or a septic condition requiring continuous kidney replacement therapy.